Foot problems & neuropathy

• A Randomized, Controlled Trial Examining Cellular Energetics and Oxygenation Levels Related to Various Wound Treatment Therapies. Must have Type II Diabetes and a diabetic foot ulcer on the bottom of the foot. IRB #: HSC20080017H. Principal Investigator: Thomas Zgonis, DPM - (210) 358-7737.

Eye disease

• No studies at this time, please check back later.

Kidney disorders

• No studies at this time, please check back later.

High blood pressure

• The Role of Inflammatory, Adipocytokines, and Insulin Signaling and Sensitivity in the Prevention of Type 2 Diabetes Mellitus in Hypertensive Subjects Treated with Valsartan. IRB# HSC20070065H. Principal Investigator: Dr. Ralph DeFronzo (210) 358-7200.

Lipid (cholesterol) abnormalities

• No studies at this time, please check back later.

Hyperbaric & wound care

• No studies at this time, please check back later.

Gland disorders (thyroid, adrenal, etc.)

1. Norditropin in Children with Growth Failure Associated with IGF Deficiency: A 12- month, open-label, Randomized, Parallel Group Study. IRB# 023-9000-148. Principal Investigator: Daniel Hale, MD-(210) 358-7550.

Osteoporosis

• No studies at this time, please check back later.

Other

• Improving Diabetes Risk Factors in Mexican-American Persons with Schizophrenia by Switching to Ziprasidone. IRB# HSC20070052H. Principal Investigator: Ralph De Fronzo (210) 358-7200.